〔Stock in Focus〕Oncolys Bio surged as much as 18%, boosted by positive market reaction to its approval for manufacturing and marketing a viral therapy for esophageal cancer.

Oncolys BioPharma Inc. (4588), listed on the Growth Market, surged sharply, rising 423 yen (18.4%) to close at 2,720 yen, driven by investor optimism following the Pharmaceutical Affairs and Food Sanitation Council of Japan's Ministry of Health, Labour and Welfare approving the company's oncolytic virus therapy—designed to eradicate esophageal cancer—for manufacturing and marketing on the 21st. The stock opened at 9:15 a.m. with strong buying interest and continued to climb thereafter. Recently, while satellite and generative AI-related stocks have attracted significant investor attention in the Growth Market, biotech shares have been trading weakly.

Jiji PressMay 21 21:27 ET

Stocks hitting upper or lower price limits in the afternoon session.

■Limit-up: <3089> Techno Alpha, <4208> UBE Corporation, <4436> Minkabu Z Infonoid, <5031> MOI Co., Ltd., <6634> JN Group Co., Ltd., <7946> Koyo-sha Co., Ltd., <9244> Digitalift Inc., <9941> Taiyo Bussan Co., Ltd. ■Limit-down: <4263> Sasmec Co., Ltd., <4588> Oncolys BioPharma Inc., <5852> Aresty Holdings Co., Ltd., <6579> Logly Co., Ltd. *Includes temporary limit-up/limit-down (indicative quotes).

Fisco JapanMay 20 02:44 ET

Express News | Daichi Gomi reported a reduction in his ownership stake in Oncolys BioPharma Inc. (4588.JP) to 3.91% in a change notification filing.

Moomoo NewsMay 20 00:21 ET

Growth 250, an emerging stock index, continued its decline on the 15th due to profit-taking.

The TSE Growth Market 250 Index continued to decline. It opened higher in the morning but lost value as time progressed. The drop is attributed to profit-taking ahead of the weekend, according to a major securities firm. Trial HD (141A), which announced its earnings on the 14th, also continued to fall. Oncolys BioPharma (4588), Syns (290A), and Okix (6521) also declined. On the other hand, ACSL (6232), Power X (485A), and QD Laser (6613) rose as their earnings were well received. In Saudi Arabia, oil...

Jiji PressMay 15 03:41 ET

Bulls and Bears: Emerging markets see mixed trading as earnings reports drive sentiment.

Growth stocks are showing a nearly balanced performance, with 48% rising and 43% falling. Market participants noted, 'There is active buying and selling based on earnings announcements' (major securities firm). Power X <485A> and ACSL <6232>, which announced their earnings the previous day, rose. QD Laser <6613>, which forecasted a return to operating profit for the fiscal year ending March 2027, surged. Terra Drone <278A> also increased in value. On the other hand, Trial HD fell after its earnings announcement.

Jiji PressMay 14 21:58 ET

BUYSELL, trials, and more

<141A> Trial Co. upwardly revised its forecast for the current fiscal year's operating profit to JPY 28.00 billion from JPY 25.40 billion. <196A> MFS upwardly revised its forecast for the current fiscal year's operating profit to JPY 200 million from JPY 195 million. <246A> Asa Co. has revised its shareholder benefits program. <269A> Sapeet Co. upwardly revised its forecast for the current fiscal year's operating profit to JPY 120 million from JPY 82 million. <2986> LAHD Co. has introduced a shareholder benefits program and implemented a stock split, increasing from 1 share to 3 shares. The interim dividend at the end of the second quarter has been raised to JPY 177.00 per share from JPY 175.00. <378

Fisco JapanMay 14 18:30 ET